摘要
目的 :探讨硫酸镁在静脉溶栓治疗急性脑梗死中的临床价值。方法 :将 12 4例急性脑梗死患者行静脉溶栓治疗 ,随机分为加用硫酸镁治疗组 6 2例 ,不加硫酸镁治疗者 6 2例作对照 ,对其疗效作对比观察。结果 :治疗组总有效率为 6 7.7% ,明显高于对照组的 32 .3% (P <0 .0 0 1)。未发现不良反应。结论 :镁剂辅佐溶栓治疗急性脑梗死能显著改善临床症状 ,降低致残率 ,安全性高。
Objective: To evaluate the clinical value of magnesium sulfate in treatrment of acute encephalorrhagia by phlebothrombolysis. Method: 124 cases, treated by thrombolysis, were randomly divided into 2 groups. 62 cases were added MgSO_4 therapy in group 1; 62 cases were served as controlled group (group 2). The results of treatment in the two groups were compared. Result: The general effective rate of the treated group was 67.7% , which was significantly higher than that of the controlled group which was 32.3% ( P < 0.001 ). No any obvious bad effects were found in this study. Conclusion: Acute encephalorrhagia treated by phlebothrombolysis with magnesium sulfate as adjuvant can significantly improve the patients' clinical symptoms, reducing the rate of disablement-induced. This treatment has high safety.
出处
《中国药师》
CAS
2003年第5期294-295,共2页
China Pharmacist
关键词
硫酸镁
脑梗死
静脉溶栓治疗
Magnesium sulfate
Encephalorrhagia
Phlebothrombolysis therapy
